Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by NESIN Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Probal Banerjee | Cancer Biology | Best Researcher Award

Published on by NESIN Awards

Prof. Probal Banerjee | Cancer Biology | Best Researcher Award

Professor| University of New York | United States

Dr. Probal Banerjee is a distinguished Professor of Chemistry and Coordinator of the Center for Developmental Neuroscience at The College of Staten Island, City University of New York, renowned for his pioneering contributions at the intersection of chemistry, neuroscience, and molecular pharmacology. Holding a Ph.D. in Bioorganic Chemistry from the Indian Institute of Science, Bangalore, and postdoctoral training at the University of Notre Dame and the University of Chicago, he has produced over 100 peer-reviewed publications that have advanced understanding of serotonergic signaling in brain development and innovative therapeutic strategies in cancer biology. His groundbreaking research on the 5-HT1A receptor’s role in neonatal hippocampal neurogenesis and on curcumin-based multi-target cancer therapies has redefined approaches to neurodevelopmental and oncological disorders, emphasizing immune modulation and translational impact. Dr. Banerjee’s recent studies on immune-friendly prodrugs and synergistic natural compounds reflect his commitment to safe, mechanism-driven, and sustainable therapeutic innovation. A frequent invited speaker at global scientific forums including Columbia University, NASA Ames, and the Indian Institute of Science, he collaborates internationally to bridge fundamental discovery with clinical relevance. Recognized with multiple honors such as the Brain Research Foundation Award and two Dolphin Awards for academic excellence and teaching, Dr. Banerjee continues to mentor emerging scientists and shape global biomedical research through his visionary work integrating molecular neuroscience, immunology, and drug development to enhance human health worldwide

Profiles: Scopus | ORCID

Featured Publications

Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension. Geroscience. 1 citation (2025).

Targeting sickle cell pathobiology and pain with novel transdermal curcumin. PNAS Nexus. 2 citations (2025).

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Frontiers in Oncology. 2 citations (2019).

Biocompatible anisole-nonlinear PEG core–shell nanogels for high loading capacity, excellent stability, and controlled release of curcumin. Gels. 8 citations (2023).

Why don’t the mutant cells that evade DNA repair cause cancer more frequently? Importance of the innate immune system in the tumor microenvironment. International Journal of Molecular Sciences. 4 citations (2023).

The G protein-coupled serotonin 1A receptor augments protein kinase Cε-mediated neurogenesis in neonatal mouse hippocampus—PKCε-mediated signaling in the early hippocampus. International Journal of Molecular Sciences. 2 citations (2022).

Dr. Probal Banerjee’s research bridges chemistry, neuroscience, and immunology to pioneer multi-target therapeutic strategies that combat cancer and neurodevelopmental disorders. His innovative work on curcumin-based immune therapies and serotonergic signaling mechanisms has advanced translational medicine, inspiring new, safer, and globally accessible approaches to human health and disease management.

Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Published on by NESIN Awards

Dr. Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Postdoctoral Fellow | City of Hope National Medical Center | United States

Dr. Imran Shair Mohammad is a distinguished pharmaceutical scientist whose research focuses on developing next-generation minimally invasive cancer immunotherapies through the design of innovative drug delivery systems and biomaterials. His work lies at the intersection of drug discovery, mRNA and peptide engineering, and biomaterial science, with an emphasis on creating nano/microparticle and hydrogel-based systems for targeted delivery of exosomes, RNA, peptides, and small molecules to improve therapeutic outcomes in cancer, inflammation, and infectious diseases. He earned his Ph.D. in Pharmaceutics from China Pharmaceutical University, Nanjing, following an M.Phil and Pharm.D. from The Islamia University of Bahawalpur, Pakistan. Professionally, Dr. Mohammad has held several postdoctoral research positions across leading international institutions, including the University of North Carolina at Chapel Hill, Erciyes University in Turkey, Sun Yat-sen University in China, and currently serves at the City of Hope National Medical Center, USA. His expertise spans drug and gene delivery, mRNA and peptide synthesis, protein engineering, and immunomodulatory biomaterials, with hands-on proficiency in nanoparticle development, polymer chemistry, and advanced analytical techniques such as HPLC, TEM, and LC-MS. His research interests encompass cancer immunotherapy, drug resistance, cellular engineering, and microbiome-based therapeutics. Dr. Mohammad has published over 40 peer-reviewed articles, received multiple international research grants from the USA, Turkey, and China, and serves on the editorial boards of Cancer Immunology Connect and Current Drug Delivery. Recognized with prestigious honors such as the High-Level Foreign Talents Award from Guangdong Province and the Chinese Government Ph.D. Scholarship, he continues to contribute to advancing translational nanomedicine and targeted immunotherapeutic strategies. His career exemplifies a commitment to scientific innovation, interdisciplinary collaboration, and impactful research that bridges laboratory discoveries with clinical applications for global health advancement.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

1. Mohammad, I. S., He, W., & Yin, L. (2018). Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomedicine & Pharmacotherapy, 100, 335–348. https://doi.org/10.1016/j.biopha.2018.02.028 Cited by: 226

2. Mohammad, I. S., Hu, H., Yin, L., & He, W. (2019). Drug nanocrystals: Fabrication methods and promising therapeutic applications. International Journal of Pharmaceutics, 562, 187–202. https://doi.org/10.1016/j.ijpharm.2019.03.055 Cited by: 163

3. Ishaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., … (2017). Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomedicine & Pharmacotherapy, 95, 865–874. https://doi.org/10.1016/j.biopha.2017.08.097 Cited by: 134

4. Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., … (2021). Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharmaceutica Sinica B, 11(8), 2585–2604. https://doi.org/10.1016/j.apsb.2021.03.013 Cited by: 130

5. Gu, Y., Mohammad, I. S., & Liu, Z. (2020). Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncology Letters, 19(4), 2585–2594. https://doi.org/10.3892/ol.2020.11309 Cited by: 120

Qiushui Wang | Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Qiushui Wang | Molecular Biology | Best Researcher Award

Associate Professor| Institute of Analysis and Testing, Beijing Academy of Science and Technology (Beijing Center for Physical and Chemical Analysis) | China

Assoc. Prof. Dr. Qiushui Wang (born August 29, 1991) is a distinguished researcher specializing in biochemistry, molecular biology, and microbial natural products, currently serving as an Associate Research Fellow at the Beijing Center for Physical & Chemical Analysis (BCPCA), Beijing Academy of Science and Technology. She earned her Ph.D. in Biochemistry and Molecular Biology from the Institute of Microbiology, Chinese Academy of Sciences (IMCAS) in 2020 under the supervision of Prof. Zhang Lixin, with part of her doctoral research conducted at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) under Prof. Dr. Rolf Müller. Her academic journey began with a Bachelor’s degree in Pharmacy from Shandong University in 2014. Dr. Wang’s research focuses on microbial natural products, CRISPR/Cas9 gene editing in actinomycetes, microbial diversity, and antibiotic resistance mechanisms. She developed the innovative pQS gene-editing system, significantly improving gene-editing efficiency in rare actinomycetes and enabling new insights into the biosynthesis and yield enhancement of key bioactive compounds such as proxmicin and griselimycin. Her current work integrates multi-omics analysis, high-throughput sequencing, and microbial genomics to explore microbial community dynamics, antibiotic resistance genes, and probiotic strain development for aquaculture and crop health. Dr. Wang has authored several influential publications in journals such as Applied Microbiology and Biotechnology, Frontiers in Microbiology, and Environmental Science. Her research skills include microbial genome engineering, bioinformatics, multi-omics data analysis, natural product discovery, and analytical chemistry (HPLC-MS/MS). She has made remarkable contributions to understanding soil–microbe–crop interactions and antibiotic resistance in aquaculture environments. Recognized for her academic excellence and innovative research, Dr. Wang has received multiple institutional honors and continues to contribute significantly to advancing microbial biotechnology and sustainable environmental health. Her interdisciplinary expertise and leadership mark her as a rising figure in biochemical and microbial research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  • Wang, Q., Xie, F., Tong, Y., Habisch, R., Yang, B., Zhang, L., Müller, R., & Fu, C. (2020). Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes. Applied Microbiology and Biotechnology, 104(1), 225–239. Cited by: 27

  • Xie, F., Dai, S., Zhao, Y., Huang, P., Yu, S., Ren, B., Wang, Q., Ji, Z., Alterovitz, G., … (2020). Generation of fluorinated amychelin siderophores against Pseudomonas aeruginosa infections by a combination of genome mining and mutasynthesis. Cell Chemical Biology, 27(12), 1532–1543.e6. Cited by: 16

  • Fu, C., Xie, F., Hoffmann, J., Wang, Q., Bauer, A., Brönstrup, M., Mahmud, T., … (2019). Armeniaspirol antibiotic biosynthesis: Chlorination and oxidative dechlorination steps affording spiro[4.4]non-8-ene. ChemBioChem, 20(6), 764–769. Cited by: 13

  • Xie, F., Dai, S., Shen, J., Ren, B., Huang, P., Wang, Q., Liu, X., Zhang, B., Dai, H., … (2015). A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239T. Applied Microbiology and Biotechnology, 99(14), 5895–5905. Cited by: 10

  • Wang, Q., Zhou, X., Liu, Y., Han, Y., Zuo, J., Deng, J., Yuan, L., Gao, L., & Bai, W. (2023). Mixed oligosaccharides-induced changes in bacterial assembly during cucumber (Cucumis sativus L.) growth. Frontiers in Microbiology, 14, 1195096. Cited by: 9

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by NESIN Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Adem Güner | Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Adem Güner | Molecular Biology | Best Researcher Award

Corresponding Author at Sinop University, Turkey

Assoc. Prof. Dr. Adem Güner is an accomplished academic specializing in biology, toxicology, cancer research, and occupational health & safety. His career reflects a strong interdisciplinary approach, integrating fundamental biological sciences with applied health innovations. He has contributed extensively to scientific research through publications in high-impact journals, covering cancer biology, nanoparticle synthesis, apoptosis mechanisms, and environmental toxicology. Early in his career, Dr. Güner explored the biological activities of marine algae and lichens, highlighting their cytotoxic, antioxidant, and protective roles. More recently, he has advanced into occupational safety research, incorporating modern tools such as virtual reality-based risk assessment and accident process management. Beyond publications, he has demonstrated leadership through departmental responsibilities, supervision of students, and participation in nationally funded projects. His active involvement in professional organizations such as EACR and MOKAD, alongside community-impact projects, further illustrates his commitment to advancing both academic knowledge and societal well-being at local and international levels.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Assoc. Prof. Dr. Adem Güner holds a strong academic background with progressive degrees in biology. He earned his Master’s degree in General Biology from Atatürk University, where he laid the foundation for his interest in cellular biology and toxicology. He then pursued doctoral research at Ege University, obtaining his Ph.D. in General Biology. During his doctoral studies, he focused on exploring the cytotoxic, antioxidant, and genoprotective properties of marine algae and lichens, producing work that connected natural product research with cancer biology. His academic training was not limited to laboratory work but also extended into applied aspects of occupational health, environmental biology, and molecular research. This educational journey has enabled him to develop expertise in both experimental biology and applied health sciences. The combination of fundamental biological studies and applied technological solutions reflects his broad perspective on using education as a bridge between science and practice.

Experience

Assoc. Prof. Dr. Güner has accumulated over a decade of academic and research experience across respected Turkish universities. He began his career as a Research Assistant at Giresun University, where he gained foundational experience in teaching, laboratory management, and collaborative research. Later, he joined Sinop University’s Faculty of Health Sciences, where he progressed through the roles of Assistant Professor and now Associate Professor. In these roles, he has conducted impactful studies in cancer research, toxicology, nanoparticle applications, and occupational safety. His involvement as a project leader and researcher in nationally funded programs, including those supported by TÜBİTAK, has strengthened his expertise in grant management and interdisciplinary teamwork. As Vice Chair of his department, he has contributed to academic governance and curriculum development. Dr. Güner’s experience also extends internationally, with memberships in leading associations such as EACR and MOKAD, which have enabled him to remain connected with global scientific advancements and collaborations.

Research Interest

Assoc. Prof. Dr. Adem Güner’s research interests span multiple disciplines, reflecting his interdisciplinary expertise. In the field of cancer biology, he investigates cytotoxicity, apoptosis, and molecular mechanisms of natural and synthetic compounds, focusing on their potential as anticancer agents. His early studies on marine algae and lichens emphasized their antioxidant and protective activities against genotoxic and oxidative stress. He also explores the role of nanoparticle synthesis in biomedical applications, especially for drug delivery and therapeutic purposes. Beyond cancer research, Dr. Güner has a strong interest in environmental toxicology, studying the effects of pollutants and chemicals on human health. More recently, his focus has expanded into occupational health and safety, where he applies innovative technologies such as virtual reality-based risk assessment and accident process modeling to prevent workplace hazards. This diverse range of interests highlights his dedication to combining fundamental biology with real-world applications, ultimately advancing both scientific understanding and societal health.

Award and Honor

Throughout his career, Dr. Adem Güner has earned recognition for his academic and research contributions in biology, toxicology, and health sciences. His research excellence has been acknowledged through nationally funded grants and projects, including support from TÜBİTAK, which underscores his ability to secure competitive funding and lead impactful investigations. As a dedicated academic, he has supervised student theses and guided young researchers, further enhancing his professional standing. His leadership roles, such as serving as Vice Chair of his department, demonstrate institutional recognition of his organizational and academic capabilities. Dr. Güner’s membership in esteemed international organizations such as The European Association for Cancer Research (EACR) and Molecular Cancer Research Association (MOKAD) reflects peer recognition of his scientific contributions and his integration into the global research community. These honors and affiliations collectively highlight his academic impact, leadership potential, and ongoing commitment to advancing research with both scientific and societal benefits.

Research Skills

Assoc. Prof. Dr. Adem Güner possesses a versatile set of research skills that combine experimental, analytical, and applied methodologies. He is proficient in cell culture techniques, cytotoxicity assays, and apoptosis analysis, enabling him to evaluate anticancer activities of natural and synthetic compounds. His expertise extends to nanoparticle synthesis and characterization, particularly in biomedical applications, and he has conducted detailed investigations in environmental toxicology, examining pollutant impacts on health. Dr. Güner also demonstrates strong skills in molecular biology techniques, including oxidative stress analysis and genotoxicity evaluation. Beyond laboratory expertise, he is adept in project management and grant acquisition, having led and contributed to multiple TÜBİTAK-funded projects. In recent years, he has developed applied research skills in virtual reality-based occupational risk assessment and accident prevention modeling, showcasing his adaptability in adopting modern technologies. His comprehensive skill set reflects not only technical proficiency but also an ability to integrate science into innovative health and safety applications.

Publication Top Notes

Title: Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies
Authors: H. Atmaca, S. İlhan, M.B. Batır, Ç.Ç. Pulat, A. Güner, H. Bektaş
Year: 2020
Citation: 51

Title: Multi-Biomarker Responses After Exposure to Pollution in the Mediterranean Mussels (Mytilus galloprovincialis L.) in the Aegean Coast of Turkey
Authors: D. Ozkan, M. Dagdeviren, S. Katalay, A. Guner, N.Ü.K. Yavaşoğlu
Year: 2017
Citation: 39

Title: Antimicrobial and antioxidant activities with acute toxicity, cytotoxicity and mutagenicity of Cystoseira compressa (Esper) Gerloff & Nizamuddin from the coast of Urla
Authors: A. Güner, C. Köksal, Ş.B. Erel, H. Kayalar, A. Nalbantsoy, A. Sukatar, …
Year: 2015
Citation: 38

Title: Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties
Authors: A. Güner, A. Nalbantsoy, A. Sukatar, N.Ü. Karabay Yavaşoğlu
Year: 2019
Citation: 35

Title: Histopathological and apoptotic changes on marine mussels Mytilus galloprovincialis (Lamark, 1819) following exposure to environmental pollutants
Authors: A. Yavaşoğlu, D. Özkan, A. Güner, S. Katalay, F. Oltulu, N.Ü.K. Yavaşoğlu
Year: 2016
Citation: 32

Title: Anticancer and antiangiogenesis activities of novel synthesized 2-substituted benzimidazoles molecules
Authors: A. Güner, E. Polatli, T. Akkan, H. Bektaş, C. Albay
Year: 2019
Citation: 20

Title: Ameliorative effect of edible Halopteris scoparia against cadmium‐induced reproductive toxicity in male mice: A biochemical and histopathologic study
Authors: Ö. Güner, A. Güner, A. Yavaşoğlu, N.Ü. Karabay Yavaşoğlu, O. Kavlak
Year: 2020
Citation: 16

Title: The cytogenetic effects of the aqueous extracts of migratory locust (Locusta migratoria L.) in vitro
Authors: H. Turkez, Ü. İncekara, A. Güner, E. Aydın, E. Dirican, B. Togar
Year: 2014
Citation: 16

Title: Apoptosis-inducing activity of safflower (Carthamus tinctorius L.) seed oil in lung, colorectal and cervix cancer cells
Authors: A. Güner, S. Kızılşahin, A. Nalbantsoy, N.Ü. Karabay Yavaşoğlu
Year: 2020
Citation: 15

Conclusion

In conclusion, Assoc. Prof. Dr. Adem Güner is highly suitable for the Best Researcher Award. His extensive contributions in cancer biology, toxicology, and occupational safety research—supported by impactful publications, funded projects, and academic mentorship—demonstrate a career dedicated to advancing both scientific knowledge and societal well-being. With his proven ability to integrate basic science with applied health technologies, he not only enriches the academic community but also addresses real-world challenges in health and safety. His future potential for leadership in international collaborations and innovative research makes him a deserving candidate for this award.

Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Published on by NESIN Awards

Dr. Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Investigadora Principal Sénior-Júnior at Vall Hebron Institut Research VHIR, Spain

Dr. Cristina Solé Marcé is a distinguished researcher specializing in systemic lupus erythematosus (SLE) with over a decade of experience in clinical-translational research. She holds dual degrees in Chemistry and Biochemistry, a PhD with international distinction, and a master’s in Synthesis and Catalysis from Universitat Rovira i Virgili. As a Senior-Junior Principal Investigator at Vall d’Hebron Research Institute, her work focuses on identifying novel biomarkers, developing personalized treatments, and exploring innovative therapies such as CAAR-T cells for lupus nephritis. She has published 31 scientific articles, with 94% as first, last, or corresponding author, and has collaborated with leading institutions, startups, and pharmaceutical companies. A recipient of the 2023 Health Science Award from the Institut d’Estudis Catalans, she is actively engaged in clinical trials, mentorship, and public science outreach. Dr. Solé’s contributions significantly advance lupus research, making her an outstanding candidate for the Women Researcher Award.

Professional Profile 

Education

Dr. Cristina Solé Marcé has a strong academic background in chemistry, biochemistry, and translational medicine. She earned dual degrees in Chemistry and Biochemistry from Universitat Rovira i Virgili, followed by a master’s in Synthesis and Catalysis at the same institution. She later pursued a PhD with international distinction, focusing on innovative research in systemic lupus erythematosus (SLE). Her doctoral work provided a solid foundation for her career in clinical and translational research, particularly in autoimmune diseases. Committed to continuous learning, Dr. Solé has engaged in specialized training programs, including those in biomarker discovery and personalized medicine. Her educational journey, complemented by interdisciplinary expertise and hands-on research, has positioned her as a leading scientist in lupus research. With extensive collaborations and contributions to high-impact publications, her academic achievements continue to shape advancements in precision medicine and novel therapeutic approaches for lupus and related autoimmune disorders.

Professional Experience

Dr. Cristina Solé Marcé is an accomplished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE). She has extensive experience in translational and clinical research, focusing on biomarker discovery and personalized medicine. Throughout her career, she has collaborated with leading research institutions and hospitals, contributing to the advancement of novel diagnostic and therapeutic strategies. Dr. Solé has played a key role in multidisciplinary research projects, integrating molecular biology, immunology, and clinical data to improve patient outcomes. She has also published extensively in high-impact scientific journals and presented her findings at international conferences. Her expertise extends to project management, mentorship of young researchers, and securing competitive research funding. Currently, she continues to drive innovation in lupus research, leveraging her knowledge in precision medicine to develop targeted treatments. Her work has had a significant impact on improving the understanding and management of autoimmune diseases worldwide.

Research Interest

Dr. Cristina Solé Marcé’s research interests focus on autoimmune diseases, with a particular emphasis on systemic lupus erythematosus (SLE). Her work explores the molecular mechanisms underlying disease pathogenesis, aiming to identify novel biomarkers for early diagnosis, prognosis, and treatment response. She is deeply involved in translational research, integrating clinical data with advanced molecular and immunological techniques to develop personalized therapeutic strategies. Dr. Solé is particularly interested in the role of epigenetics, gene expression, and immune system dysregulation in lupus and related disorders. Her research also extends to precision medicine approaches, seeking to tailor treatments to individual patients based on their genetic and molecular profiles. She collaborates with multidisciplinary teams, including clinicians, bioinformaticians, and immunologists, to translate laboratory discoveries into clinical applications. Through her work, Dr. Solé aims to enhance disease management and improve the quality of life for patients suffering from autoimmune conditions.

Award and Honor

​Dr. Cristina Solé Marcé is a distinguished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Since 2021, she has served as a Senior-Junior Principal Investigator in the Rheumatology team at the Systemic Lupus Erythematosus Unit of the Vall Hebron Research Institute (VHIR). Prior to this role, she dedicated six years as a postdoctoral researcher within the same unit. Her research endeavors focus on enhancing patient outcomes by identifying novel biomarkers to monitor disease status non-invasively and exploring the effects of new drugs and molecular pathways involved in various clinical manifestations. This work has led to multiple publications in internationally recognized journals and invitations to present at prestigious conferences such as the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR).

Research Skill

Dr. Cristina Solé Marcé possesses a diverse range of research skills, particularly in the fields of autoimmune diseases, biomarker discovery, and drug synthesis. She has extensive experience in molecular biology techniques, biochemical assays, and analytical chemistry, which she applies to her studies on systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Her expertise includes non-invasive biomarker identification to improve disease monitoring and understanding the mechanisms of action of novel therapeutic agents. With a strong background in synthetic chemistry, she has worked on the enantioselective synthesis of drugs and the development of anticancer compounds. Additionally, she is skilled in experimental design, data analysis, and scientific communication, with multiple publications in high-impact journals and presentations at international conferences such as ACR and EULAR. Her interdisciplinary approach, combining chemistry, biochemistry, and immunology, enables her to contribute significantly to translational research and patient-centered advancements in rheumatology.

Conclusion

Dr. Cristina Solé Marcé is a highly accomplished researcher with an impressive track record in autoimmune disease research, particularly lupus. Her combination of scientific excellence, leadership, international collaboration, and patient engagement makes her a compelling candidate for the Women Researcher Award. Strengthening her funding profile and expanding her research applications could further solidify her impact. Given her current achievements, she is well-deserving of recognition through this award.

Publications Top Noted

  • Solé et al., 2025 – Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus. Int. J. Mol. Sci. DOI: 10.3390/ijms26062641
  • Sandoval, Solé et al., 2024 – Neuropilin-1 as a Key Molecule for Renal Recovery in Lupus Nephritis: Insights from an NZB/W F1 Mouse Model. Int. J. Mol. Sci. DOI: 10.3390/ijms252111364
  • Solé et al., 2024 – Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells. Int. J. Mol. Sci. DOI: 10.3390/ijms25084226
  • Solé et al., 2023 – Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS). Int. J. Mol. Sci. DOI: 10.3390/ijms241411607
  • Solé et al., 2023 – Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2022.08.036
  • Solé et al., 2022 – Humoral and Cellular Response in Convalescent COVID-19 Lupus Patients. Sci. Rep. DOI: 10.1038/s41598-022-17334-5
  • Domingo, Solé et al., 2021 – Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways. Biomedicines. DOI: 10.3390/biomedicines9121857
  • Domingo, Solé et al., 2020 – Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology. DOI: 10.1159/000508672
  • Domingo, Solé et al., 2020 – MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus, and Atopic Dermatitis. Cells. DOI: 10.3390/cells9122656
  • Garcia-Vives, Solé et al., 2020 – The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis. Int. J. Mol. Sci. DOI: 10.3390/ijms21041372
  • Solé et al., 2019 – MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2018.07.026

Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Prof. Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

College teachers at Guangdong Pharmaceutical University, China

Professor Ze-Min Yang is a distinguished researcher specializing in metabolic disease pathogenesis and pharmacological research integrating Traditional Chinese Medicine (TCM) with Western medicine. With over 40 academic publications, including 13 SCI-indexed papers, and three invention patents, he has made significant contributions to biomedical research. He has led multiple prestigious projects, including National Natural Science Foundation grants and provincial research collaborations, demonstrating strong leadership and innovation. Serving as Deputy Director at Guangdong Pharmaceutical University, he plays a key role in academic mentorship and scientific evaluation at the provincial level. His accolades, such as “Outstanding Science and Technology Worker” and “Outstanding Teacher,” further highlight his excellence. While his research output is impressive, enhancing international collaborations, increasing citation impact, and expanding interdisciplinary applications could further strengthen his global recognition. Overall, his achievements and leadership make him a strong candidate for the Best Researcher Award, recognizing his impactful contributions to science and medicine.

Professional Profile 

Education

Professor Ze-Min Yang has a strong academic foundation spanning multiple disciplines. He earned his Ph.D. in 2012 from the Institute of Spleen and Stomach Research at Guangzhou University of Traditional Chinese Medicine, specializing in integrated traditional Chinese and Western medicine clinical practice. Prior to this, he obtained a Master’s degree in Hydrobiology from the Hydrobiology Research Center of Jinan University in 2005, demonstrating his expertise in biological sciences. His academic journey began with a Bachelor’s degree in Freshwater Fisheries from the Department of Fisheries at Southwest Agricultural University in 2002. This diverse educational background has provided him with a unique interdisciplinary perspective, integrating biomedical sciences, traditional medicine, and hydrobiology. His advanced training and research experience have contributed to his expertise in metabolic disease pathogenesis and pharmacological research, reinforcing his position as a leading academic in the field of biomedical and pharmaceutical sciences.

Professional Experience

Professor Ze-Min Yang has an extensive professional background in biomedical and pharmaceutical sciences. He currently serves as a faculty member in the Department of Biochemistry and Molecular Biology at the School of Basic Medical Sciences, Guangdong Pharmaceutical University. Additionally, he holds the position of Deputy Director of the Experimental Teaching Center, where he plays a key role in advancing scientific research and education. His expertise is recognized at the provincial level, as he actively contributes as an expert in science and technology project evaluation and acceptance for both Guangdong Province and Guangzhou City. Throughout his career, he has led multiple prestigious research projects, including those funded by the National Natural Science Foundation and Guangdong Provincial Science and Technology Department. His leadership in academic research, combined with his contributions to scientific evaluation and mentorship, underscores his dedication to advancing biomedical sciences and fostering innovation in traditional Chinese and Western medicine integration.

Research Interest

Professor Ze-Min Yang’s research interests focus on the pathogenesis of metabolic diseases and the pharmacological effects of integrating Traditional Chinese Medicine (TCM) with Western medicine. His work explores innovative approaches to understanding and treating metabolic disorders through a combination of molecular biology, biochemistry, and traditional herbal medicine. He is particularly interested in identifying bioactive compounds in TCM that can be used for drug development and disease management. His interdisciplinary research extends to studying the mechanisms of metabolic regulation, inflammation, and gut microbiota interactions in disease progression. By bridging modern biomedical research with traditional healing practices, he aims to develop novel therapeutic strategies that are both scientifically validated and culturally relevant. His contributions, supported by multiple national and provincial research grants, significantly advance the integration of TCM with evidence-based medicine, enhancing its global recognition and application in modern healthcare.

Award and Honor

Professor Ze-Min Yang has received numerous awards and honors in recognition of his outstanding contributions to scientific research, education, and innovation. He has been honored with titles such as “Outstanding Science and Technology Worker,” “Advanced Teaching Worker,” and “Outstanding Teacher” by Guangdong Pharmaceutical University, reflecting his excellence in both research and academia. His leadership in biomedical sciences and commitment to integrating Traditional Chinese Medicine with Western medicine have earned him prestigious recognition at institutional and provincial levels. Additionally, his contributions as an expert in science and technology project evaluation for Guangdong Province and Guangzhou City highlight his influence in shaping research policies and advancements. With multiple funded projects, over 40 academic publications, and three invention patents, his work has significantly impacted the field of metabolic disease research. These accolades reinforce his reputation as a distinguished scientist and educator, making him a strong candidate for prestigious research awards.

Research Skill

Professor Ze-Min Yang possesses a diverse and advanced set of research skills, particularly in the fields of biochemistry, molecular biology, and pharmacology. His expertise lies in investigating the pathogenesis of metabolic diseases and the therapeutic potential of Traditional Chinese Medicine (TCM) integrated with Western medicine. He has extensive experience in experimental design, data analysis, and clinical applications, allowing him to bridge theoretical research with practical medical solutions. His work involves drug discovery, biomarker identification, and molecular mechanism studies, utilizing cutting-edge laboratory techniques such as cell culture, gene expression analysis, and bioinformatics. Additionally, his ability to lead multi-disciplinary research projects, secure national and provincial funding, and collaborate with experts in biomedical sciences demonstrates his strong project management and leadership skills. His contributions, including over 40 academic publications and three patents, highlight his ability to drive innovative research that advances both scientific knowledge and clinical applications.

Conclusion

Professor Ze-Min Yang is a strong candidate for the Best Researcher Award due to his extensive research in metabolic diseases, leadership in TCM and Western medicine integration, multiple prestigious grants, and significant academic contributions. To further enhance his profile, international collaborations, higher-impact publications, and broader interdisciplinary work would strengthen his candidacy.

Publications Top Noted

  • Title: “Identification of microRNA and analysis of target genes in Panax ginseng”

    Authors: Yingfang Wang, Yanlin Chen, Mengyuan Peng, Yongqin Yin, Yu Zeng

    Year: 2023

    Citations: 8

    Source: Chinese Herbal Medicines

  • Title: “Astragalus Polysaccharides Alleviate Type 2 Diabetic Rats by Reversing the Expressions of Sweet Taste Receptors and Genes Related to Glycolipid Metabolism in Liver”

    Authors: Mengjuan Luo, Ying Wang, Siyu Chen, Zemin Yang

    Year: 2022

    Citations: 14

    Source: Frontiers in Pharmacology

Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Erzincan Üniversitesi, Turkey

Dr. Ahmet Altay is an accomplished researcher and academic in the field of chemistry, specializing in biochemistry, medicinal chemistry, and interdisciplinary sciences. With a strong background in natural product chemistry and anticancer drug discovery, he has contributed significantly to the scientific community through his research on antioxidants, cytotoxic agents, and enzyme inhibition. His extensive publication record in high-impact SCI-Expanded journals highlights his expertise in experimental and computational studies. Currently serving as an Associate Professor at Erzincan Binali Yıldırım University, Dr. Altay continues to push the boundaries of chemical and biochemical research, focusing on novel therapeutic compounds and their biological applications.

Professional Profile 

Education

Dr. Ahmet Altay earned his Ph.D. in Biochemistry from Middle East Technical University (METU), Turkey, in 2015. His doctoral research focused on the antioxidant and cytotoxic properties of Salvia fruticosa M., as well as its effects on cytochrome P450 enzymes and antioxidant gene expression in colon cancer cells.

Professional Experience

Dr. Altay has been a faculty member at Erzincan Binali Yıldırım University since 2016. He started as an Assistant Professor (2016-2018), was promoted to Associate Professor in 2020, and has since been actively involved in research and teaching. His work spans multiple disciplines within chemistry and biochemistry, with a strong focus on drug discovery and molecular interactions. His contributions include supervising graduate students, securing research grants, and collaborating on international scientific projects.

Research Interests

Dr. Ahmet Altay’s research interests lie at the intersection of biochemistry, medicinal chemistry, and pharmacology, with a particular focus on drug discovery and natural product chemistry. His work extensively explores the antioxidant, anticancer, and enzyme-inhibitory properties of bioactive compounds derived from medicinal plants. He is also deeply engaged in molecular docking studies to understand drug-receptor interactions at a computational level. Additionally, his research investigates apoptosis mechanisms, oxidative stress-related disorders, and the modulation of key metabolic pathways in cancer and neurodegenerative diseases. By integrating experimental and computational approaches, Dr. Altay aims to develop novel therapeutic agents that can target cancer, microbial infections, and enzyme-related disorders. His interdisciplinary research combines chemical synthesis, molecular modeling, and pharmacological evaluation to provide innovative solutions in biomedical sciences.

Awards and Honors

Dr. Ahmet Altay has received multiple awards and recognitions for his outstanding contributions to scientific research and academia. His excellence in publishing high-impact research has been acknowledged with best paper awards and recognitions from international conferences and scientific organizations. He has been honored with research grants and funding support for his projects on natural product chemistry and drug discovery. As an active academic, he has also received accolades for his contributions to student mentorship and scientific collaboration. His efforts in cancer research and enzyme inhibition studies have been recognized by national and international institutions. Additionally, his role as a peer reviewer and editorial board member in prestigious scientific journals highlights his expertise and influence in the field. These awards and honors underscore his dedication to advancing biomedical and pharmaceutical sciences.

Research Skills

Dr. Ahmet Altay possesses a diverse set of research skills spanning experimental and computational methodologies. His expertise includes the isolation and structural characterization of bioactive natural products using advanced chromatographic and spectroscopic techniques such as HPLC, GC-MS, and NMR. He is highly proficient in molecular docking, molecular dynamics simulations, and in silico drug design to predict ligand-target interactions. His skills in biochemical assays enable the evaluation of antioxidant, antimicrobial, and anticancer activities of synthetic and natural compounds. Additionally, he has extensive experience in enzyme kinetics, apoptosis studies, and gene expression analysis using RT-PCR and Western blot techniques. His interdisciplinary knowledge allows him to integrate synthetic chemistry, pharmacology, and bioinformatics to address complex biomedical challenges. Dr. Altay’s strong analytical skills, coupled with his experience in mentoring and collaboration, make him a leading researcher in his field.

Conclusion

Dr. Ahmet Altay is a strong candidate for the Best Researcher Award due to his high research output, international collaborations, and contributions to anticancer and biochemical research. To enhance his profile further, he could focus on leading large-scale projects, securing more grants, and publishing in top-tier journals. Nonetheless, his achievements make him a compelling nominee for this award.

Publications Top Noted

  • Title: Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1

    • Authors: Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2024
    • Citation: Naunyn-Schmiedeberg’s Archives of Pharmacology
    • DOI: 10.1007/s00210-024-02980-5

  • Title: The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells

    • Authors: Esma Kübra Kağan Yeniçeri, Ahmet Altay
    • Year: 2024
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1376859

  • Title: Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells

    • Authors: Şükran Günaydın, Emine Karaca Sulukoğlu, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4505

  • Title: Effect of evernic acid on human breast cancer MCF‐7 and MDA‐MB‐453 cell lines via thioredoxin reductase 1: A molecular approach

    • Authors: Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4451

  • Title: In Vitro Cytotoxic Evaluation of a Silver(I) Complex Including Non-Steroidal Anti-Inflammatory Drug Niflumic Acid and 3-Picoline on Human-Derived Cancer Cell Lines

    • Authors: Sema Çağlar, Ahmet Altay, Bülent Çağlar, Esma Kübra Kağan Yeniçeri, Betül Harurluoğlu
    • Year: 2022
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1130634

  • Title: A Biochemical Approach for Hedysarum candidissimum from Turkey: Screening Phytochemicals, Evaluation of Biological Activities, and Molecular Docking Study

    • Authors: Ahmet Altay, Esma Yeniceri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yilmaz, Ekrem Koksal
    • Year: 2022
    • Citation: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202200348

  • Title: Phytochemical Analysis and Biological Evaluation of Hypericum linarioides Bosse: in Vitro and in Silico Studies

    • Authors: Ahmet Altay, Esma Kübra Kağan Yeniçeri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yılmaz, Ekrem Köksal
    • Year: 2022
    • Citation: ChemistrySelect
    • DOI: 10.1002/slct.202200039